Physician profile
Constantine Gorelick
NPI 1700051612
$1,695.05
in general payments reported to CMS, 2019-2025
16 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $124 · 2021: $128 · 2022: $353 · 2023: $311 · 2024: $207 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $513.04 | 2020-2025 | Jemperli, Zejula |
| Astrazeneca Pharmaceuticals LP | $254.13 | 2020-2025 | Lynparza |
| Eisai INC. | $174.95 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $159.88 | 2019-2025 | Lynparza |
| Hologic Sales and Service, LLC | $145.27 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myriad Women'S Health, INC. | $96.77 | 2023 | Myrisk |
| Myriad Genetic Laboratories, INC. | $92.33 | 2021-2022 | |
| Clovis Oncology, INC. | $58.67 | 2020-2021 | |
| Genmab U.S., INC. | $49.36 | 2024 | Tivdak |
| Caris Mpi, INC. | $42.64 | 2025 | Mi Cancer Seek |
| Foundation Medicine, INC. | $23.13 | 2019 | |
| Teleflex LLC | $18.53 | 2020 | |
| Daiichi Sankyo INC. | $18.09 | 2022 | |
| Momentis Surgical INC. | $18.00 | 2022 | |
| Roche Diagnostics Corporation | $15.17 | 2025 | Cobas Liat Analyzer |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $15.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Gorelick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.